Insider Buyers At Acelyrin Likely Disappointed With 11% Slide
Insider Buyers At Acelyrin Likely Disappointed With 11% Slide
The recent price decline of 11% in Acelyrin, Inc.'s (NASDAQ:SLRN) stock may have disappointed insiders who bought US$2.65m worth of shares at an average price of US$18.00 in the past 12 months. Insiders buy with the expectation to see their investments rise in value over a period of time. However, recent losses have rendered their above investment worth US$1.35m which is not ideal.
最近Acelyrin, Inc.的價格下跌了11%。”s(納斯達克股票代碼:SLRN)的股票可能讓內部人士失望,他們在過去12個月中以平均18.00美元的價格購買了價值265萬美元的股票。業內人士買入是期望他們的投資在一段時間內升值。但是,最近的虧損使他們的上述投資價值135萬美元,這並不理想。
Although we don't think shareholders should simply follow insider transactions, we do think it is perfectly logical to keep tabs on what insiders are doing.
儘管我們認爲股東不應簡單地關注內幕交易,但我們確實認爲密切關注內部人士的所作所爲是完全合乎邏輯的。
View our latest analysis for Acelyrin
查看我們對 Acelyrin 的最新分析
Acelyrin Insider Transactions Over The Last Year
Acelyrin 過去一年的內幕交易
In the last twelve months, the biggest single purchase by an insider was when Independent Director Beth Seidenberg bought US$1.1m worth of shares at a price of US$18.00 per share. That means that even when the share price was higher than US$9.13 (the recent price), an insider wanted to purchase shares. It's very possible they regret the purchase, but it's more likely they are bullish about the company. In our view, the price an insider pays for shares is very important. It is generally more encouraging if they paid above the current price, as it suggests they saw value, even at higher levels.
在過去的十二個月中,內部人士最大的單筆收購是獨立董事貝絲·塞登伯格以每股18美元的價格購買了價值110萬美元的股票。這意味着,即使股價高於9.13美元(最近的價格),內部人士也想購買股票。他們很有可能對這次收購感到遺憾,但他們更有可能看好該公司。在我們看來,內部人士爲股票支付的價格非常重要。如果他們支付的價格高於當前價格,通常會更令人鼓舞,因爲這表明即使在更高的水平上,他們也看到了價值。
In the last twelve months Acelyrin insiders were buying shares, but not selling. The chart below shows insider transactions (by companies and individuals) over the last year. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!
在過去的十二個月中,Acelyrin內部人士在買入股票,但沒有賣出股票。下圖顯示了去年的內幕交易(公司和個人)。如果你點擊圖表,你可以看到所有的個人交易,包括股價、個人和日期!
Acelyrin is not the only stock that insiders are buying. For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.
Acelyrin並不是內部人士唯一買入的股票。對於那些喜歡尋找中獎投資的人來說,這份最近有內幕收購的成長型公司的免費名單可能只是門票。
Insider Ownership Of Acelyrin
Acelyrin 的內部所有權
Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. A high insider ownership often makes company leadership more mindful of shareholder interests. Insiders own 2.5% of Acelyrin shares, worth about US$22m. This level of insider ownership is good but just short of being particularly stand-out. It certainly does suggest a reasonable degree of alignment.
檢驗公司領導者與其他股東之間一致性的另一種方法是查看他們擁有多少股票。較高的內部人所有權通常會使公司領導層更加關注股東的利益。業內人士擁有Acelyrin2.5%的股份,價值約2200萬美元。這種內部所有權水平不錯,但還差一點特別突出。當然,這確實表明了一定程度的一致性。
So What Does This Data Suggest About Acelyrin Insiders?
那麼,這些數據對Acelyrin Insiders有何啓示呢?
There haven't been any insider transactions in the last three months -- that doesn't mean much. On a brighter note, the transactions over the last year are encouraging. Overall we don't see anything to make us think Acelyrin insiders are doubting the company, and they do own shares. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Acelyrin. To help with this, we've discovered 4 warning signs (3 are a bit unpleasant!) that you ought to be aware of before buying any shares in Acelyrin.
在過去的三個月中,沒有任何內幕交易——這並不意味着什麼。令人鼓舞的是,去年的交易令人鼓舞。總的來說,我們認爲沒有任何東西可以讓我們認爲Acelyrin內部人士正在懷疑該公司,他們確實擁有股票。除了了解正在進行的內幕交易外,確定Acelyrin面臨的風險也是有益的。爲了幫助解決這個問題,我們發現了 4 個警告標誌(3 個有點不愉快!)在購買Acelyrin的任何股票之前,你應該意識到這一點。
If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.
如果你想看看另一家公司——一家財務狀況可能優越的公司——那麼千萬不要錯過這份免費的股本回報率高、債務低的有趣公司的名單。
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
就本文而言,內部人士是指向相關監管機構報告其交易的個人。我們目前只考慮公開市場交易和私下處置的直接利益,不包括衍生品交易或間接權益。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。